Research.Patient.info
Refractory Chronic Cough, Including Unexplained Chronic Cough research hub
2 indexed studies · 2 currently recruiting
- recruitingTherapeutic confirmatory (Phase III)
A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-Label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough, Including Unexplained Chronic Cough (CALM-1)
This clinical trial is testing a new daily tablet called BLU-5937 for adults with a long-term cough that has not responded to treatment or has no clear cause. Researchers want to see if the medicine can safely reduce how often people cough over a 24-hour period.
Netherlands · Poland · Belgium - recruitingTherapeutic confirmatory (Phase III)
A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough Including Unexplained Chronic Cough (CALM-2)
This study is testing a new tablet, called BLU-5937, for adults with a chronic cough that will not go away despite usual treatments. Researchers want to see if taking the tablet for 24 weeks safely reduces how often people cough during the day and night.
Germany · Slovakia · Czechia